These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
440 related items for PubMed ID: 19370693
1. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF. Cochrane Database Syst Rev; 2009 Apr 15; (2):CD007784. PubMed ID: 19370693 [Abstract] [Full Text] [Related]
2. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF. Cochrane Database Syst Rev; 2014 May 31; (5):CD007784. PubMed ID: 24880031 [Abstract] [Full Text] [Related]
3. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF. Cochrane Database Syst Rev; 2009 Apr 15; (2):CD005019. PubMed ID: 19370615 [Abstract] [Full Text] [Related]
4. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF. Cochrane Database Syst Rev; 2014 Jan 28; 2014(1):CD005019. PubMed ID: 24470059 [Abstract] [Full Text] [Related]
5. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Tunnicliffe DJ, Palmer SC, Cashmore BA, Saglimbene VM, Krishnasamy R, Lambert K, Johnson DW, Craig JC, Strippoli GF. Cochrane Database Syst Rev; 2023 Nov 29; 11(11):CD007784. PubMed ID: 38018702 [Abstract] [Full Text] [Related]
6. HMG CoA reductase inhibitors (statins) for dialysis patients. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. Cochrane Database Syst Rev; 2009 Apr 15; (2):CD004289. PubMed ID: 19370598 [Abstract] [Full Text] [Related]
7. HMG CoA reductase inhibitors (statins) for dialysis patients. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. Cochrane Database Syst Rev; 2009 Jul 08; (3):CD004289. PubMed ID: 19588351 [Abstract] [Full Text] [Related]
8. HMG CoA reductase inhibitors (statins) for dialysis patients. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF. Cochrane Database Syst Rev; 2013 Sep 11; 2013(9):CD004289. PubMed ID: 24022428 [Abstract] [Full Text] [Related]
9. HMG CoA reductase inhibitors (statins) for dialysis patients. Navaneethan SD, Shrivastava R. Cochrane Database Syst Rev; 2004 Oct 18; (4):CD004289. PubMed ID: 15495097 [Abstract] [Full Text] [Related]
10. Lipid-lowering agents for nephrotic syndrome. Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L. Cochrane Database Syst Rev; 2013 Dec 10; (12):CD005425. PubMed ID: 24327265 [Abstract] [Full Text] [Related]
11. Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia. Izquierdo-Palomares JM, Fernandez-Tabera JM, Plana MN, Añino Alba A, Gómez Álvarez P, Fernandez-Esteban I, Saiz LC, Martin-Carrillo P, Pinar López Ó. Cochrane Database Syst Rev; 2016 Nov 26; 11(11):CD009462. PubMed ID: 27888640 [Abstract] [Full Text] [Related]
12. Antioxidants for chronic kidney disease. Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, Webster AC, Perkovic V. Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD008176. PubMed ID: 23076940 [Abstract] [Full Text] [Related]
13. Statins for the primary prevention of cardiovascular disease. Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S. Cochrane Database Syst Rev; 2013 Jan 31; 2013(1):CD004816. PubMed ID: 23440795 [Abstract] [Full Text] [Related]
14. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF. Ann Intern Med; 2012 Aug 21; 157(4):263-75. PubMed ID: 22910937 [Abstract] [Full Text] [Related]
15. Pentoxifylline for diabetic kidney disease. Shan D, Wu HM, Yuan QY, Li J, Zhou RL, Liu GJ. Cochrane Database Syst Rev; 2012 Feb 15; (2):CD006800. PubMed ID: 22336824 [Abstract] [Full Text] [Related]
16. Statins for the primary prevention of cardiovascular disease. Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, Ebrahim S. Cochrane Database Syst Rev; 2011 Jan 19; (1):CD004816. PubMed ID: 21249663 [Abstract] [Full Text] [Related]
17. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants. Barylski M, Nikfar S, Mikhailidis DP, Toth PP, Salari P, Ray KK, Pencina MJ, Rizzo M, Rysz J, Abdollahi M, Nicholls SJ, Banach M, Lipid and Blood Pressure Meta-Analysis Collaboration Group. Pharmacol Res; 2013 Jun 19; 72():35-44. PubMed ID: 23542730 [Abstract] [Full Text] [Related]
18. Aldosterone antagonists for preventing the progression of chronic kidney disease. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Cochrane Database Syst Rev; 2009 Jul 08; (3):CD007004. PubMed ID: 19588415 [Abstract] [Full Text] [Related]
19. The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-analysis. Zhang Z, Wu P, Zhang J, Wang S, Zhang G. Pharmacol Res; 2016 Mar 08; 105():74-83. PubMed ID: 26776964 [Abstract] [Full Text] [Related]
20. Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis. Su X, Zhang L, Lv J, Wang J, Hou W, Xie X, Zhang H. Am J Kidney Dis; 2016 Jun 08; 67(6):881-92. PubMed ID: 26905361 [Abstract] [Full Text] [Related] Page: [Next] [New Search]